The 4WHIM clinical research study is now enrolling people living with WHIM syndrome. The goals of this Phase 3 study are to learn if the investigational oral drug, mavorixafor, can help people with WHIM syndrome by targeting the way the disease works and if it can safely reduce bacterial infections and warts.
Considering a clinical trial? Learn more about clinical research studies so you can make an informed decision.
Check out questions to ask your doctor, videos, toolkits and more–designed for people with rare diseases and those who want to learn more about clinical trials.
